Givaudan stock holds near record levels as sales and margins stay firm

Givaudan stock (ISIN CH0010645932) remains anchored by 2025 results that showed sales of CHF 7.41 billion, recurring EBITDA of CHF 1.66 billion and a recurring EBITDA margin of 23.0%, according to the company’s latest investor materials. Net profit for 2025 reached CHF 893 million, giving investors a fresh baseline for margin and earnings quality.

CHF 7.41 billion sales

The 2025 revenue figure of CHF 7.41 billion is the key top-line anchor, and it sits alongside recurring EBITDA of CHF 1.66 billion, which underlines how much of Givaudan’s profile still depends on pricing power and mix. The margin of 23.0% shows that the group kept profitability at a level that many consumer and ingredients peers only approach after several quarters of recovery.

That earnings structure matters because Givaudan is a large listed supplier to the flavor and fragrance market, where volume growth can be uneven but contract breadth and formulation work often soften cyclicality. The 2025 net profit of CHF 893 million also gives the stock a clear profit reference point for the current year.

Margin at 23.0%

For investors, the 23.0% recurring EBITDA margin is more useful than the revenue headline alone because it shows how efficiently the company converted CHF 7.41 billion of sales into operating earnings in 2025. A business with recurring EBITDA of CHF 1.66 billion and net profit of CHF 893 million is typically judged less on short-term sentiment and more on durability.

The comparison also works across time: if sales stay near the 2025 level while the margin holds around 23.0%, earnings leverage remains intact. If the margin slips, the market usually reacts more quickly than it does to a minor change in top-line growth.

Fragrance mix matters

Givaudan’s product range spans flavors, fragrances and related ingredients, and that mix is important because it supports customer retention even when consumer demand shifts. The company’s 2025 net profit of CHF 893 million suggests the portfolio still converts a broad customer base into earnings rather than relying on one product cycle.

That is the main product angle for the stock: the market values not only sales volume but also formulation depth, contract renewal and pricing resilience. In 2025, recurring EBITDA of CHF 1.66 billion and a 23.0% margin showed both operating scale and discipline.

Swiss listing backdrop

Givaudan trades on the SIX Swiss Exchange, and the stock is typically assessed in Swiss francs because that is the currency of its financial reporting and domestic market context. The company’s 2025 figures - sales of CHF 7.41 billion, recurring EBITDA of CHF 1.66 billion and net profit of CHF 893 million - remain the most concrete published reference points available for the equity story.

As of 24 July 2026, the share price reference should be read against that earnings base and the group’s 2025 profitability profile. The stock is still best judged by whether future reporting keeps the margin near 23.0% while preserving earnings around the CHF 893 million level.